MB "Biomedicininės konsultacijos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
8,535 |
- |
74 |
70 |
- |
100.00 |
0.82 |
2,288 |
4 |
1,699 |
593 |
2023 |
---|
11,710 |
- |
119 |
113 |
- |
100.00 |
0.96 |
2,401 |
8 |
918 |
1,491 |
2024 |
---|
9,626 |
- |
-215 |
-215 |
- |
100.00 |
-2.23 |
2,186 |
1,661 |
171 |
3,676 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
9,626 €-18 % *
Sales per employee (€)
-Profit before tax (€)
-215 €-281 % *
Net Profit (€)
-215 €-290 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-2.23 %-332.29 % *
Equity (€)
2,186 €-9 % *
Amounts Payable And Liabilities (€)
1,661 €20,663 % *
Non-current Assets (€)
171 €-81 % *
CurrentAssets (€)
3,676 €147 % *